Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel preparation method reduces cost and improves yield for Vortioxetine manufacturing ensuring supply chain stability and high purity standards for global pharmaceutical partners
Patent CN113528472B details a novel P450 BM3 mutant route for Trenbolone Acetate. Discover cost reduction in steroid manufacturing and high-purity intermediate supply strategies.
Patent CN105779522B details high-yield enzymatic synthesis. Offers scalable production and purity for pharmaceutical supply chains.
Novel 2-step synthesis of ethyl 24-cholenoate with high yield. Ideal for reliable pharmaceutical intermediate supplier seeking cost-effective Vitamin D3 metabolite precursors.
Efficient 6-step route to (+)-γ-lycorane from lactone. High purity, scalable process for pharma intermediates reducing cost and lead time.
Novel synthesis of catechol compounds via cyclohexanone and sulfone. High yield, scalable process for pharma and agrochemical intermediates.
Novel synthesis method for florfenicol analogue intermediate ensures high purity and cost reduction in veterinary drug manufacturing supply chains.
Patent CN106117169B reveals a Grignard-based route for 2,5-furandicarboxylic acid. This method offers mild conditions and high purity for reliable supply chain integration.
Patent CN101142211B details a robust resolution process for cis-oxathiolane cytosine derivatives, offering significant cost reduction and supply chain reliability for antiviral API manufacturing.
Patent CN107778349A details a low-cost GHK acetate synthesis. Trt protection ensures purity and eliminates TFA, offering supply chain advantages.
Discover a scalable stereoselective process for chiral 2-[(hetero)aralkylthio]pyrimidines. Achieve high chiral purity without chiral HPLC for cost-effective API manufacturing.
Novel Lesinurad synthesis patent CN106866560A offers high yield and purity. Ideal for reliable pharmaceutical intermediates supplier seeking cost reduction.
Novel preparation method for Dolutegravir Impurity A and B via CN110655517A. Offers high-purity reference standards and scalable routes for HIV drug quality control.
Patent CN109678853A reveals ionic liquid catalysis for Dasatinib. Enhances purity and supply chain reliability for pharmaceutical intermediate manufacturing partners globally.
Novel synthetic route for 5-trifluoromethyl pyrrole-2-formic acid via sodium triflinate. Improved yield and purification for reliable pharma intermediate supply.
Patent CN1332948C details a solvent-free synthesis of bis-indolyl derivatives using SO4 2-/TiO2, offering significant cost reduction and environmental benefits for pharmaceutical intermediate manufacturing.
Novel patent CN111454164B details efficient terbutaline sulfate synthesis reducing toxic waste and enhancing supply chain reliability for global pharmaceutical intermediates supplier networks.
Patent CN101824012B reveals a novel route for 2-(1,6,7,8-tetrahydro-2H-indeno-[5,4-b]furan-8-yl)acetonitrile, offering cost reduction in API manufacturing and high purity.
Patent CN117567288A details a novel asymmetric hydrogenation process for chiral alcohols, offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN102382091A reveals a mild one-step route to chromones using benzyne chemistry, offering cost reduction in API manufacturing and reliable supply.